Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-08

Clinical Trial Update: Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous nitrite infusion to reverse cerebral vasospasm after subarachnoid hemorrhage was terminated, with results posted in Febru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium nitrite intravenous infusion (sodium nitrite)

Snippet

Sponsor: Hope Pharmaceuticals | Conditions: Subarachnoid Hemorrhage | Phase 2 | Status: TERMINATED | Results posted: 2018-02-08